Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Product introduced for institutional channel in the US market The post Glenmar...
The agreement covers the promotion license, sales, and distribution of CARTISTEM...
In patients suffering with oHCM, myosin inhibition with MYQORZO, which is an all...
Under the agreement, Novartis has voluntarily committed to several actions. Thes...
Company begins commercial distribution of Novo Nordisk product for weight manag...
Brand marks six decades of skincare use and portfolio expansion The post Pirama...
Approval covers multiple strengths for ADHD treatment, to be manufactured at US...
The initiative aims to shape future standards and safeguards for the way AI is u...
The approval covers all existing indications for Rybrevant. The SC formulation r...
Cipla to market and distribute five Pfizer medicines in India under new agreeme...
FL is the most common slow-growing B-cell non-Hodgkin lymphoma form. Minjuvi is ...
This is claimed to become the first fully dedicated small-interfering RNA (siRNA...
Alembic Pharmaceuticals Limited (Alembic) announced that it has received final ...
Harbour BioMed will work alongside BMS to progress and expedite the programmes a...
Senores Pharmaceuticals announced that it has entered into a definitive agreeme...
Lupin has announced that the Committee for Medicinal Products for Human Use (CH...